Prestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025. In the quarter to June 2026, revenue grew 6.48%, EPS fell 36.5%, free cash flow fell 14.2% and total debt rose 100.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow PBH
Prestige Consumer Healthcare Inc. (PBH) P/E ratio
As of 16 October 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a P/E ratio of 13.9×. Over the past ten years it has ranged from 0.0× (March 2024) to 44.0× (July 2016); the current reading is higher than 39% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 15.0× | (24.41%) |
| FY2025 | 19.9× | 16.88% |
| FY2024 | 17.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 13.0× | (3.45%) |
| FY2021 | 13.4× | 3.32% |
| FY2020 | 13.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 5.2× | (87.75%) |
| FY2017 | 42.1× | 49.00% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 13.2× | (12.47%) |
| Mar 2026 | 15.0× | (7.09%) |
| Dec 2025 | 16.2× | 5.35% |
| Sep 2025 | 15.4× | (17.23%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| XERS Xeris Biopharma Holdings, Inc. compare | n/m |
| PRGO Perrigo Company plc compare | n/m |
| BCRX BioCryst Pharmaceuticals, Inc. compare | n/m |
| ALVO Alvotech compare | n/m |
| SUPN Supernus Pharmaceuticals, Inc. compare | n/m |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | n/m |
| PBH Prestige Consumer Healthcare Inc. | 13.9× |
| ANIP ANI Pharmaceuticals, Inc. compare | 14.9× |
| LQDA Liquidia Corporation compare | 21.9× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)